Top News

• Biotech Leaders Support Access to Mifepristone
• FDA Drops REMS Need for ERA Meds
• CGMP Violations at Exela Pharma Sciences
• Support for Biosimilar Legislation
• FDA Prodded to Improve Surrogate Endpoint Transparency
• Taiho Reports Unfavorable DMD Drug Data
• FDA Urged to Expand Real-World Data Use
• Multiple Insightra Medical Violations Cited